Axiostat Patch

GUDID 00860008768629

Axiostat Patch is intended for local management of bleeding wounds and to provide a barrier to bacterial penetration of the dressing for patients and for the rapid control of moderate to severe bleeding. The dressing is indicated for the following wounds: lacerations, abrasions, surgical debridement sites, skin surface puncture sites, vascular procedure sites and sites involving percutaneous catheters, tubes and pins.

Advamedica Inc.

Chitosan haemostatic agent, professional
Primary Device ID00860008768629
NIH Device Record Key6f8da637-bc05-4634-9742-c69c04cde54a
Commercial Distribution StatusIn Commercial Distribution
Brand NameAxiostat Patch
Version Model NumberV35
Company DUNS118526617
Company NameAdvamedica Inc.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS100860008768629 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

FRODressing, Wound, Drug

Sterilization

Steralize Prior To Usefalse
Device Is Steriletrue

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2023-12-25
Device Publish Date2023-12-16

On-Brand Devices [Axiostat Patch ]

00860008768629Axiostat Patch is intended for local management of bleeding wounds and to provide a barrier to b
00860008768605Axiostat Patch is intended for local management of bleeding wounds and to provide a barrier to b
00860008768681Axiostat Patch is intended for local management of bleeding wounds and to provide a barrier to b

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.